Emergent BioSolutions on Tuesday announced that it entered into an agreement to acquire Adapt Pharma for up to $735 million, gaining the latter's Narcan (naloxone) nasal spray. Daniel Abdun-Nabi......
Adapt Pharma will donate 20,000 cartons (40,000 doses) of NARCAN® (naloxone hydrochloride) Nasal Spray 4mg to colleges and universities throughout the United States.